Nuance Audio Glasses Get FDA Clearance, EU Certifications
EssilorLuxottica has received FDA clearance and CE marking for its Nuance Audio Glasses, a smart eyewear solution featuring integrated open-ear hearing aid technology.
Tag: FDA
All
Latest
All
Latest
Oticon’s Sentio System Gets U.S. FDA Clearance
Oticon's new active transcutaneous bone conduction hearing system offers an alternative to existing percutaneous systems.
All
Latest
Neuromod Devices’ Lenire Receives De Novo Approval from FDA
Neuromod Devices' Lenire, a bimodal neuromodulation device, has received De Novo approval from the FDA to treat tinnitus. According to the company, Lenire is the first of its kind to receive FDA approval.
Sontro Hearing Aids Win BIG Innovation Award
The Sontro Hearing Aids (Model AI) are wireless, self-programming hearing aids that have been developed to amplify sound for individuals 18 years or older with perceived mild-to-moderate hearing impairment.
Read More
Dr Robert Califf ‘Narrowly Confirmed’ By Senate to Lead FDA
Robert Califf received Senate confirmation as commissioner of the US Food and Drug Administration (FDA) today.
Read More
Knowles Introduces New Balanced Armature Receiver for OTC Market
Knowles Corporation, a provider of advanced micro-acoustic microphones, speakers, audio solutions, high-performance capacitors, and RF products, announced the RAQ, a new medium-power balanced armature receiver developed for high-volume hearing health and TWS products.
Read More
Healthcare Equality Network Requests Changes to Proposed OTC Hearing Aid Rule
The Healthcare Equality Network (HEN)—a group advocating for equal, quality access to healthcare for Black Americans—recently wrote a letter to the Food and Drug Administration (FDA) proposing changes to the OTC Hearing Aid Rule.
Read More
CES 2022 and OTC Hearing Aids
Wireless earbuds and innovative audio solutions were one of the predominant themes of this year’s Consumer Electronics Show (CES) in Las Vegas. Here are HR Editor Karl Strom’s three takeaways from CES2022 regarding innovation and the upcoming OTC hearing aid category.
Read More
GN Launches Jabra Enhance Plus Earbuds
GN announced availability of the “first-of-its-kind innovative Jabra Enhance Plus earbuds engineered for hearing enhancement” in the US on February 25.
Read More
Eargo Supports Proposed Rule for OTC Hearing Aids
Eargo, Inc (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, announced the submission of public comments to the Food and Drug Administration (FDA) concerning its proposed rule to create a new regulatory category of over the counter (OTC) hearing aids.
Read More
Oticon Medical Announces FDA Clearance of Ponto 5 SuperPower
Introducing ‘full SuperPower strength in the smallest SuperPower device ever available, the Ponto 5 SuperPower also delivers significant advancements in sound processor technology – including a patented feature to prevent audible feedback – along with a sleek cosmetic design,” according to the company.
Read More
HLAA Files Comments to FDA for OTC Hearing Aid Rule
The Hearing Loss Association of America (HLAA) announced that it filed comments to the Food and Drug Administration (FDA) on its proposed rule establishing Over-the-Counter (OTC) hearing aids. Once finalized by the FDA, consumers 18 and older with mild-to- moderate hearing loss will be able to purchase hearing aids at retail and online outlets.
Read More
NAAG Urges FDA to Preserve State Regulation of OTC Hearing Aids
The National Association of Attorneys General (NAAG) cautions that OTC hearing aid rules currently under review by the FDA may unintentionally hinder or repeal important consumer protection authorities, undermining states’ ability to ensure safe and affordable access to hearing aids. Currently, all 50 states have hearing professional licensing requirements and many have important protections for hearing aid consumers, including advertising restrictions, as well as mandatory warrantees and returns.
Read More
HIA Responds to Proposed FDA OTC Hearing Aid Rule
The Hearing Industries Association (HIA) announced that it has submitted comments in response to the proposed over-the-counter (OTC) hearing aid rules published by the Food and Drug Administration (FDA) on October 20, 2021.
Read More
Cochlear Nucleus Receives FDA Approval for UHL/SSD
Cochlear implants are already FDA approved for those with moderate-to-profound bilateral sensorineural hearing loss. With this approval, Cochlear can expand implantable treatment options for those with UHL/SSD to include cochlear implants, for the first time, according to its announcement.
Read More
Gene Therapy for Hearing Loss Reversal
Hearing loss has been linked to mutations in at least 100 different genes, but up to 16% of genetic hearing loss can be traced to just one gene, STRC, the second most common genetic cause. A first-of-its-kind gene therapy technique developed at Boston Children’s Hospital successfully replaced the mutated protein, stereocilin, in the inner ear and reversed severe hearing loss in mice — sometimes to normal levels of hearing.
Read More
Fennec Does Not Expect FDA Approval for Pedmark
Fennec Pharmaceuticals Inc, a company developing a drug to help prevent cisplatin-related hearing loss in children, announced that it expects the FDA to decline its marketing application for Pedmark, “Reuters” reported.
Read More
Neuromod USA Appoints Teri Minard As Director, Gov Sales
Neuromod Devices Ltd, the medical device company which specializes in neuromodulation technologies, has announced the appointment of Teri Minard as Director, Government Sales of its recently established US entity, Neuromod USA Inc.
Read More